awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q54222874-2ADA6DF8-DA9E-43D9-B8C5-59A041FDFECB
Q54222874-2ADA6DF8-DA9E-43D9-B8C5-59A041FDFECB
BestRank
Statement
http://www.wikidata.org/entity/statement/Q54222874-2ADA6DF8-DA9E-43D9-B8C5-59A041FDFECB
Anti-retroviral drugs: current state and development in the next decade.
P2860
Q54222874-2ADA6DF8-DA9E-43D9-B8C5-59A041FDFECB
BestRank
Statement
http://www.wikidata.org/entity/statement/Q54222874-2ADA6DF8-DA9E-43D9-B8C5-59A041FDFECB
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
46428f71099b86ff9ffb448a7787f235cc8cb055
P2860
Cabotegravir plus rilpivirine, once a day, after induction with cabotegravir plus nucleoside reverse transcriptase inhibitors in antiretroviral-naive adults with HIV-1 infection (LATTE): a randomised, phase 2b, dose-ranging trial.